Press Releases

Tillotts Pharma AG announces the launch of Octasa® 800mg Tablets in Canada

Tillotts Pharma AG has announced the recent launch of Octasa® 800mg (mesalazine) delayed-release tablets, as first-line treatment for moderately active ulcerative colitis (UC) in Canada.

Recipharm strengthens pre-filled syringe and cartridge offering with new investment

END Contact information For media enquiries, please contact Imogen Quail, PR Manager, at ramarketing: imogen.quail@ramarketingpr.com, +44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, LinkedIn: /ramarketing About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. For more information on Recipharm and our services, please visit www.recipharm.com 1Source Safety Prefilled Syringe Market Size is expected to reach (globenewswire.com) Recipharm AB Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.com

Biopharma PEG Provides Large Scale PEG Derivatives Applied In The Pharmaceutical Industry

Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study

Creative Diagnostics announced the launch of Monkeypox Virus Antigens and Antibodies to support scientists focused on the research of monkeypox virus.

Amerigo Scientific Launches PicoRaman Spectrometer for Time-resolved Measurements

Amerigo Scientific recently announced the launch of its new PicoRaman Spectrometer for biological and pharmaceutical applications.

STEMart Launches Biological Indicator Sterility Testing Service for Medical Devices

STEMart has recently introduced Biological Indicator Sterility Testing services for the industry of medical devices.

Cytel to acquire SDS Life Science and SDS MedteQ to enhance and expand thought-leadership in strategic therapeutic development

ytel Inc. has entered into an agreement to acquire SDS Life Science AB and SDS MedteQ AB.

Samsung Biologics obtains three global ISO certifications

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today it has successfully renewed its ISO 27001 certification (Information Security Management System) and obtained ISO 27017 certification (Information Security in cloud services) and ISO 37001 certification (Anti-bribery management systems).

CDMO Services Released by Alfa Chemistry Offer New Possibilities for Pharmaceutical Development & Manufacturing

Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide.

Celegence unveils next level efficiencies for eCTD compliance with new functionality added to Dossplorer™

New functionality added to advanced dossier management solution to bring greater efficiencies to eCTD compliance

Indica Labs and Hamamatsu Photonics K.K. Announce Collaboration to Provide Optimized Integrated Digital Pathology Workflows

Indica Labs and Hamamatsu Photonics K.K. have announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.

Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility

Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK.

BioIVT Opens New Blood Donor Center in Glasgow, Scotland

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe.

Bora Pharmaceutical makes strategic appointment to strengthen global manufacturing capabilities.

Huateng Pharma Develops A novel chemiluminescent Substrate APS-5

TransCelerate BioPharma Appoints Janice Chang as New CEO

CD Formulation Strengthens Its Role as a CRO Company for Pharmaceuticals

Combining robust expertise and years of experience, the US-based company CD Formulation further strengthens its role as a contract service provider for pharmaceutical companies in a recent statement.

Samsung Biologics unlocks additional capacity for production at its newest Plant 4

Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program

Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing accelerator, today announced an update on the development of Oxilio’s OXL001 product.

Sharp Adds New Talent with Clinical Leadership Appointments

Sharp, a leading provider of pharmaceutical packaging and clinical services, has strengthened its clinical leadership team with the appointment of Robert Feltz as Director, Analytical and Formulation Services and Michael MacNeir as Vice President, Global Business Development.